Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Pharmacology|April 29, 2021
Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant RecipientsAmelia R Cossart, Nicole M Isbel, Carla Scuderi, et al.
The Journal of Sports Medicine and Physical Fitness|July 6, 2016
Feasibility of higher intensity exercise in patients with chronic kidney diseaseKassia S Beetham, Erin J Howden, Rathika Krishnasamy, et al.
Therapeutic Drug Monitoring|February 21, 2018
Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant RecipientsEmily K Brooks, Susan E Tett, Nicole M Isbel, et al.
Transplantation|December 24, 2005
Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?Kirsten A Armstrong, David W Johnson, Scott B Campbell, et al.
Translational Andrology and Urology|June 26, 2019
Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patientsAmelia R Cossart, W Neil Cottrell, Scott B Campbell, et al.
Drugs & Aging|September 29, 2022
Exploring Transplant Medication-Taking Behaviours in Older Adult Kidney Transplant Recipients: A Qualitative Study of Semi-Structured InterviewsAmelia R Cossart, Christine E Staatz, Nicole M Isbel, et al.
Transplantation Reviews (Orlando, Fla.)|December 10, 2023
The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: A systematic reviewCatherine P King, Amelia R Cossart, Nicole M Isbel, et al.
Drugs|August 25, 2011
Once- versus twice-daily tacrolimus: are the formulations truly equivalent?Katherine A Barraclough, Nicole M Isbel, David W Johnson, et al.
Nephrology (Carlton, Vic.)|August 20, 2005
Impact of obesity on renal transplant outcomesKirsten A Armstrong, Scott B Campbell, Carmel M Hawley, et al.
American Heart Journal|March 1, 2006
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular functionNicole M Isbel, Brian Haluska, David W Johnson, et al.
Pageof 15